Global Cell and Gene Therapy Bioassay Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Cell and Gene Therapy Bioassay Services
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Cell and Gene Therapy Bioassay Services by Type
  • 1.3.1 Overview: Global Cell and Gene Therapy Bioassay Services Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type in 2022
  • 1.3.3 Cell Therapy
  • 1.3.4 Gene Therapy
• 1.4 Global Cell and Gene Therapy Bioassay Services Market by Application
  • 1.4.1 Overview: Global Cell and Gene Therapy Bioassay Services Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Pharmaceutical Company
  • 1.4.3 Biotechnology
  • 1.4.4 Others
  • 1.4.5 Mucopolysaccharidosis (MPS) Type lV A
  • 1.4.6 Others
• 1.5 Global Cell and Gene Therapy Bioassay Services Market Size & Forecast
• 1.6 Global Cell and Gene Therapy Bioassay Services Market Size and Forecast by Region
  • 1.6.1 Global Cell and Gene Therapy Bioassay Services Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Cell and Gene Therapy Bioassay Services Market Size by Region, (2018-2029)
  • 1.6.3 North America Cell and Gene Therapy Bioassay Services Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Cell and Gene Therapy Bioassay Services Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size and Prospect (2018-2029)
  • 1.6.6 South America Cell and Gene Therapy Bioassay Services Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Cell and Gene Therapy Bioassay Services Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Anabiotec
  • 2.1.1 Anabiotec Details
  • 2.1.2 Anabiotec Major Business
  • 2.1.3 Anabiotec Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.1.4 Anabiotec Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Anabiotec Recent Developments and Future Plans
• 2.2 Ccrm
  • 2.2.1 Ccrm Details
  • 2.2.2 Ccrm Major Business
  • 2.2.3 Ccrm Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.2.4 Ccrm Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Ccrm Recent Developments and Future Plans
• 2.3 Nexelis
  • 2.3.1 Nexelis Details
  • 2.3.2 Nexelis Major Business
  • 2.3.3 Nexelis Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.3.4 Nexelis Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Nexelis Recent Developments and Future Plans
• 2.4 Pacific Biolabs
  • 2.4.1 Pacific Biolabs Details
  • 2.4.2 Pacific Biolabs Major Business
  • 2.4.3 Pacific Biolabs Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.4.4 Pacific Biolabs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Pacific Biolabs Recent Developments and Future Plans
• 2.5 Ppd Laboratories
  • 2.5.1 Ppd Laboratories Details
  • 2.5.2 Ppd Laboratories Major Business
  • 2.5.3 Ppd Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.5.4 Ppd Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Ppd Laboratories Recent Developments and Future Plans
• 2.6 Intertek Pharmaceutical Services
  • 2.6.1 Intertek Pharmaceutical Services Details
  • 2.6.2 Intertek Pharmaceutical Services Major Business
  • 2.6.3 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.6.4 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Intertek Pharmaceutical Services Recent Developments and Future Plans
• 2.7 Lonza
  • 2.7.1 Lonza Details
  • 2.7.2 Lonza Major Business
  • 2.7.3 Lonza Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.7.4 Lonza Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 Lonza Recent Developments and Future Plans
• 2.8 Porton Biopharma Ltd
  • 2.8.1 Porton Biopharma Ltd Details
  • 2.8.2 Porton Biopharma Ltd Major Business
  • 2.8.3 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.8.4 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Porton Biopharma Ltd Recent Developments and Future Plans
• 2.9 Wuxi Advanced Therapies
  • 2.9.1 Wuxi Advanced Therapies Details
  • 2.9.2 Wuxi Advanced Therapies Major Business
  • 2.9.3 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.9.4 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Wuxi Advanced Therapies Recent Developments and Future Plans
• 2.10 Avomeen
  • 2.10.1 Avomeen Details
  • 2.10.2 Avomeen Major Business
  • 2.10.3 Avomeen Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.10.4 Avomeen Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Avomeen Recent Developments and Future Plans
• 2.11 Charles River Laboratories
  • 2.11.1 Charles River Laboratories Details
  • 2.11.2 Charles River Laboratories Major Business
  • 2.11.3 Charles River Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.11.4 Charles River Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 Charles River Laboratories Recent Developments and Future Plans
• 2.12 Absorption Systems
  • 2.12.1 Absorption Systems Details
  • 2.12.2 Absorption Systems Major Business
  • 2.12.3 Absorption Systems Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.12.4 Absorption Systems Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 Absorption Systems Recent Developments and Future Plans
• 2.13 Bioagilytix Labs
  • 2.13.1 Bioagilytix Labs Details
  • 2.13.2 Bioagilytix Labs Major Business
  • 2.13.3 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.13.4 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.13.5 Bioagilytix Labs Recent Developments and Future Plans
• 2.14 Catalent Inc
  • 2.14.1 Catalent Inc Details
  • 2.14.2 Catalent Inc Major Business
  • 2.14.3 Catalent Inc Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.14.4 Catalent Inc Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.14.5 Catalent Inc Recent Developments and Future Plans
• 2.15 Svar Life Science Ab
  • 2.15.1 Svar Life Science Ab Details
  • 2.15.2 Svar Life Science Ab Major Business
  • 2.15.3 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Product and Solutions
  • 2.15.4 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2018-2023)
  • 2.15.5 Svar Life Science Ab Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Cell and Gene Therapy Bioassay Services Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Cell and Gene Therapy Bioassay Services by Company Revenue
  • 3.2.2 Top 3 Cell and Gene Therapy Bioassay Services Players Market Share in 2022
  • 3.2.3 Top 6 Cell and Gene Therapy Bioassay Services Players Market Share in 2022
• 3.3 Cell and Gene Therapy Bioassay Services Market: Overall Company Footprint Analysis
  • 3.3.1 Cell and Gene Therapy Bioassay Services Market: Region Footprint
  • 3.3.2 Cell and Gene Therapy Bioassay Services Market: Company Product Type Footprint
  • 3.3.3 Cell and Gene Therapy Bioassay Services Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Cell and Gene Therapy Bioassay Services Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Cell and Gene Therapy Bioassay Services Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Cell and Gene Therapy Bioassay Services Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2018-2029)
• 6.2 North America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2018-2029)
• 6.3 North America Cell and Gene Therapy Bioassay Services Market Size by Country
  • 6.3.1 North America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2018-2029)
  • 6.3.2 United States Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Cell and Gene Therapy Bioassay Services Consumption Value by Type (2018-2029)
• 7.2 Europe Cell and Gene Therapy Bioassay Services Consumption Value by Application (2018-2029)
• 7.3 Europe Cell and Gene Therapy Bioassay Services Market Size by Country
  • 7.3.1 Europe Cell and Gene Therapy Bioassay Services Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 7.3.3 France Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region
  • 8.3.1 Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Region (2018-2029)
  • 8.3.2 China Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 8.3.5 India Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2018-2029)
• 9.2 South America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2018-2029)
• 9.3 South America Cell and Gene Therapy Bioassay Services Market Size by Country
  • 9.3.1 South America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country
  • 10.3.1 Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Cell and Gene Therapy Bioassay Services Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Cell and Gene Therapy Bioassay Services Market Drivers
• 11.2 Cell and Gene Therapy Bioassay Services Market Restraints
• 11.3 Cell and Gene Therapy Bioassay Services Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Cell and Gene Therapy Bioassay Services Industry Chain
• 12.2 Cell and Gene Therapy Bioassay Services Upstream Analysis
• 12.3 Cell and Gene Therapy Bioassay Services Midstream Analysis
• 12.4 Cell and Gene Therapy Bioassay Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source